 It was my pleasure to interview editor and author Jonathan Gluck about his 20-year battle with multiple myeloma, which he chronicles in his new memoir, An Exercise in Uncertainty. READ MORE HERE.
0 Comments
 To read about the recent removal of vaccine panel experts and the dropping of charges against a Utah doctor who destroyed COVID shots so he could give children saline shots instead leaves me disheartened, to say the least. That's why I'm proud to partner with the American Lung Association in my role at HealthCentral to produce a deeply reported and medically vetted analysis of the latest research on long COVID, with leading scientists sharing how the coronavirus can cause systemic damage and lingering illness, which affects some 38 million Americans, according to Statista. READ IT HERE.
 Everyone—both homeowners and renters—needs to understand the connection between radon exposure and lung cancer risk. I confess that before shepherding this special report for HealthCentral, produced in partnership with the American Lung Association, I was unaware that never-smokers with lung cancer now comprise a growing segment of all LC cases—and that radon is the second-leading cause of lung cancer in the U.S. after smoking. LEARN MORE HERE.
 This special report that I pitched and shepherded for HealthCentral examines why women and teen girls experience adverse drug reactions (ADRs) at between a third to double the frequency as men do, no matter where they live in the world. Remember, an ADR occurs after taking an Rx or OTC drug AS DIRECTED by a physician or drug manufacturer—these are not accidental overdoses (which are called adverse drug events, or ADEs). The evidence suggests that treating female bodies as default males in many clinical drug trials may be behind the disturbing gender gap. Now, consider that more than 1.25 million ADRs occurred in the U.S. in 2022 (the latest numbers available), with at least 175,000 Americans dying of one that year. What's more, research shows that fewer than 5% of all ADRs are estimated to be reported. So, what is being done to fix the female-ADR problem? Reporter Claire Gillespie does a deep-dive to find out. READ IT HERE.
 Happy to share this oil painting I finally finished of my two daughters, inspired by a trip we took to France last summer.
 I've been on the COVID beat for HealthCentral since passengers were infected on cruise ships back in February 2020. And our editorial team first asked if COVID-19 could be chronic in early 2021. As the initial wave of research on the fallout from the novel coronavirus was arriving in our in-boxes, we shed light on the experiences and testimonies of everyday Americans who'd been infected. Millions were living with unusual, life-upending, and sometimes painful post-infection symptoms that lingered for many weeks or months—even after a negative test suggested they’d cleared the virus. Now, four years after the global health crisis changed the way all humans work and interact with one another, a new 265-page report from the National Academies of Sciences, Engineering, and Medicine, commissioned by the Social Security Administration, confirms what we’ve long suspected: Infection from COVID can lead to lingering symptoms and long-term, possibly permanent disability. What's more, the report officially categorizes long COVID as a chronic disease. Ace reporter Michele G. Sullivan spoke to Ziyad Al-Aly, M.D., the director of the Clinical Epidemiology Center at the VA St. Louis Health Care System in Missouri, one of 14 researchers and clinical experts who were tapped to create this wide-ranging document. READ OUR Q&A HERE.
 Here's my most recent oil painting that celebrates partnership: "25 Years."
Self-portrait with husband; 12"x12"; oil on canvas; all rights reserved.  For a larger editorial feature on how women of color face life-threatening health disparities when it comes to breast cancer, I conducted a video interview with leading researcher, oncologist, and hematologist Evelyn Taiwo, M.D. Read the interview here.
 Just realized I never shared on this page HealthCentral's Medical Gaslighting Survival Guide, a patient-empowering series that I kicked off with a truly eye-opening reader survey and my summation of it.
 A breast cancer diagnosis for women of color in the U.S. usually means lower rates of genetic testing, fewer screenings and follow-ups, later diagnoses when metastasis has already occurred, and higher mortality rates. And Black women have have higher rates of more aggressive, triple-negative breast cancer, as well as documented differences in tumor biology when compared to white women. For this deep dive into the disparities that Black, Hispanic, Latina, Native American, and Asian American women face in this country after a BC diagnosis, I interviewed Evelyn Taiwo, M.D., a hematologist/oncologist at Weill Cornell Medicine and New York-Presbyterian Brooklyn Methodist Hospital in New York City, to outline why they occur, working closely with reporter Holly St. Lifer for this multimedia, multicultural guide. Click here to read the story and watch my video interview with Dr. Taiwo.
|
